natgillin/translations-raw huggingface dataset:
NovoMix 30 Penfill 100 units/ml Suspension for injection in cartridge
NovoMix 30 Penfill 100 enot/ml suspenzija za injiciranje v injekcijskem vložku
NovoMix 30 Penfill and NovoMix 30 FlexPen:
NovoMix 30 Penfill in NovoMix 30 FlexPen:
NovoMix 30 Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Zdravilu NovoMix 30 Penfill je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
NovoMix 30 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles.
Zdravilo NovoMix 30 Penfill je namenjeno za uporabo v sistemih za dajanje insulina Novo Nordisk in iglami NovoFine ali NovoTwist.
NovoMix 30 will start to lower your blood sugar 10–20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 24 hours.
Zdravilo NovoMix 30 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje do 24 ur.
NovoMix 50 and NovoMix 70 can only be used in adults (aged 18 years or over).
Zdravili NovoMix 50 in NovoMix 70 se lahko uporabljata samo pri odraslih (starih 18 let ali več).
NovoMix 50 and NovoMix 70 gave better overall control of blood glucose than biphasic human insulin 30.
Zdravili NovoMix 50 in NovoMix 70 sta na splošno bolje uravnavali raven glukoze v krvi kot dvofazni humani insulin 30.
NovoMix 50 and NovoMix 70 have been compared with biphasic human insulin 30 in 664 patients with type 1 or type 2 diabetes.
Zdravili NovoMix 50 in NovoMix 70 so primerjali z dvofaznim humanim insulinom 30 pri 664 bolnikih s sladkorno boleznijo tipa 1 ali 2.
NovoMix 50 contains 50% soluble and 50% protamine-crystallised insulin aspart;
NovoMix 50 vsebuje 50 % topnega in 50 % s protaminom kristaliziranega insulina aspart,
NovoMix 50 FlexPen 100 units/ml Suspension for injection
NovoMix 50 FlexPen 100 enot/ml suspenzija za injiciranje
NovoMix 50 FlexPen 100 units/ml suspension for injection in a pre-filled pen
NovoMix 50 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
NovoMix 50 FlexPen 100 units/ml Suspension for injection in pre-filled pen
NovoMix 50 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
NovoMix 50 FlexPen is a pre-filled pen designed to be used with NovoFine or NovoTwist needles.
Zdravilo NovoMix 50 FlexPen je napolnjen injekcijski peresnik, namenjen za uporabo z iglami NovoFine ali NovoTwist.
NovoMix 50 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid- acting and intermediate-acting insulin aspart in the ratio 50/50.
Injekcijski peresnik NovoMix 50 FlexPen je napolnjen, barvno kodiran injekcijski peresnik za enkratno uporabo, ki vsebuje mešanico hitrodelujočega in srednjedolgodelujočega insulina aspart v razmerju 50/50.
NovoMix 50 FlexPen is colour-coded and accompanied by a package leaflet with detailed instructions for use to be followed.
Barvno kodiranim injekcijskim peresnikom NovoMix 50 FlexPen je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
NovoMix 50 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediate- acting effect, in the ratio 50/50.
Zdravilo NovoMix 50 je sodobni insulin (insulinski analog), s hitrim in s srednjedolgim delovanjem, v razmerju 50/50.
NovoMix 50 is presented as a suspension for injection in a pre-filled pen.
Zdravilo NovoMix 50 je na voljo v obliki suspenzije za injiciranje v napolnjenem injekcijskem peresniku.
NovoMix 50 must not be administered intravenously, as it may result in severe hypoglycaemia.
Zdravila NovoMix 50 se ne sme aplicirati intravensko, ker lahko povzroči hudo hipoglikemijo.
NovoMix 50 Penfill 100 units/ml Suspension for injection
NovoMix 50 Penfill 100 enot/ml suspenzija za injiciranje
NovoMix 50 Penfill 100 units/ml suspension for injection in a cartridge
NovoMix 50 Penfill 100 enot/ml suspenzija za injiciranje v injekcijskem vložku
NovoMix 50 Penfill 100 units/ml Suspension for injection in cartridge
NovoMix 50 Penfill 100 enot/ml suspenzija za injiciranje v injekcijskem vložku
NovoMix 50 Penfill and NovoMix 50 FlexPen:
NovoMix 50 Penfill in NovoMix 50 FlexPen:
NovoMix 50 Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Zdravilu NovoMix 50 Penfill je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
NovoMix 50 will start to lower your blood sugar 10–20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14–24 hours.
Zdravilo NovoMix 50 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje med 14 in 24 ur.
NovoMix 70 contains 70% soluble and 30% protamine-crystallised insulin aspart.
NovoMix 70 vsebuje 70 % topnega in 30 % s protaminom kristaliziranega insulina aspart.
NovoMix 70 FlexPen 100 units/ml Suspension for injection
NovoMix 70 FlexPen 100 enot/ml suspenzija za injiciranje
NovoMix 70 FlexPen 100 units/ml suspension for injection in a pre-filled pen
NovoMix 70 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
NovoMix 70 FlexPen 100 units/ml suspension for injection in pre-filled pen
NovoMix 70 FlexPen 100 enot/ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
NovoMix 70 FlexPen is a pre-filled pen designed to be used with NovoFine or NovoTwist needles.
Zdravilo NovoMix 70 FlexPen je napolnjen injekcijski peresnik, namenjen za uporabo z iglami NovoFine ali NovoTwist.
NovoMix 70 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid- acting and intermediate-acting insulin aspart in the ratio 70/30.
Injekcijski peresnik NovoMix 70 FlexPen je napolnjen, barvno kodiran injekcijski peresnik za enkratno uporabo, ki vsebuje mešanico hitrodelujočega in srednjedolgodelujočega insulina aspart v razmerju 70/30.
NovoMix 70 FlexPen is colour-coded and accompanied by a package leaflet with detailed instructions for use to be followed.
Barvno kodiranim injekcijskim peresnikom NovoMix 70 FlexPen je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
NovoMix 70 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediate- acting effect, in the ratio 70/30.
Zdravilo NovoMix 70 je sodobni insulin (insulinski analog), s hitrim in s srednjedolgim delovanjem, v razmerju 70/30.
NovoMix 70 is indicated for treatment of diabetes mellitus in adults.
Zdravilo NovoMix 70 je namenjeno zdravljenju sladkorne bolezni pri odraslih.
NovoMix 70 Penfill 100 units/ml Suspension for injection
NovoMix 70 Penfill 100 enot/ml suspenzija za injiciranje
NovoMix 70 Penfill 100 units/ml suspension for injection in a cartridge
NovoMix 70 Penfill 100 enot/ml suspenzija za injiciranje v injekcijskem vložku
NovoMix 70 Penfill 100 units/ml Suspension for injection in cartridge
NovoMix 70 Penfill 100 enot/ml suspenzija za injiciranje v injekcijskem vložku
NovoMix 70 Penfill and NovoMix 70 FlexPen:
NovoMix 70 Penfill in NovoMix 70 FlexPen:
NovoMix 70 Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Zdravilu NovoMix 70 Penfill je priloženo navodilo za uporabo s podrobnimi napotki za uporabo, ki jih je treba upoštevati.
NovoMix 70 Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles.
Zdravilo NovoMix 70 Penfill je namenjeno za uporabo v sistemih za dajanje insulina Novo Nordisk in iglami NovoFine ali NovoTwist.
NovoMix 70 will start to lower your blood sugar 10–20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14–24 hours.
Zdravilo NovoMix 70 začne sladkor v krvi zniževati v 10 do 20 minutah po injiciranju, doseže največji učinek v 1 do 4 urah po injiciranju in deluje med 14 in 24 ur.
NovoMix contains insulin aspart in two forms: the soluble form, which works within 10 minutes of injection and the crystallised form, which is absorbed much more slowly during the day.
Zdravilo NovoMix vsebuje insulin aspart v dveh oblikah: v topni obliki, ki učinkuje v 10 minutah po injiciranju, ter v kristalizirani obliki, ki se čez dan absorbira veliko počasneje.
NovoMix contains the active substance insulin aspart (100 units [U] per millilitre) in three forms:
Zdravilo NovoMix vsebuje zdravilno učinkovino insulin aspart (100 enot (e.) na mililiter) v treh oblikah:
NovoMix doses might also need to be adjusted when given with other medicines that may have an effect on blood glucose levels.
Odmerke zdravila NovoMix bo morda treba prilagoditi, če se zdravilo daje skupaj z drugimi zdravili, ki lahko vplivajo na raven glukoze v krvi.
NovoMix is a range of suspensions for injection, which are available in cartridges (Penfill) and prefilled pens (FlexPen).
Zdravilo NovoMix je serija suspenzij za injiciranje, ki so na voljo v vložkih (Penfill) ali napolnjenih injekcijskih peresnikih (FlexPen).
NovoMix is a replacement insulin that is very similar to the insulin made by the pancreas.
Zdravilo NovoMix je nadomestni insulin, ki je zelo podoben insulinu, ki ga proizvaja trebušna slinavka.
NovoMix is injected under the skin of the abdominal wall (tummy) or the thigh.
Zdravilo NovoMix se injicira pod kožo v trebušno steno (trebuh) ali stegno.
NovoMix is used to treat diabetes.
Zdravilo NovoMix se uporablja za zdravljenje sladkorne bolezni.
NovoMix should not be used in people who may be hypersensitive (allergic) to insulin aspart or to any of the other ingredients.
Zdravila NovoMix ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) insulin aspart ali katero koli drugo sestavino zdravila.
NovoNorm may not be suitable for you.
Zdravljenje z zdravilom NovoNorm pri vas morda ni primerno.
NovoNorm tablets are round and convex and engraved with the Novo Nordisk logo (Apis bull).
Tablete NovoNorm so okrogle in izbočene ter imajo vrezan logo družbe Novo Nordisk (bik Apis).
NovoRapid 100 units/ml solution for injection Insulin aspart
NovoRapid 100 enot/ml raztopina za injiciranje
NovoRapid 100 units/ml solution for injection Insulin aspart
NovoRapid 100 enot/ml raztopina za injiciranje insulin aspart
NovoRapid can be used in adolescents and children aged 1 year and above.
Zdravilo NovoRapid se lahko uporablja pri mladostnikih in otrocih, starih 1 leto ali več.
NovoRapid FlexPen 100 units/ml solution for injection Insulin aspart
NovoRapid FlexPen 100 enot/ml raztopina za injiciranje
NovoRapid FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Zdravilo NovoRapid FlexPen je barvno kodirani napolnjen injekcijski peresnik, namenjen za uporabo z iglami za enkratno uporabo NovoFine ali NovoTwist, dolžine do 8 mm.
NovoRapid FlexPen is a pre-filled, colour–coded, disposable pen containing insulin aspart.
NovoRapid FlexPen je barvno-kodirani napolnjen injekcijski peresnik za enkratno uporabo, ki vsebuje insulin aspart.
NovoRapid FlexTouch 100 units/ml solution for injection Insulin aspart
NovoRapid FlexTouch 100 enot/ml raztopina za injiciranje
NovoRapid FlexTouch is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
NovoRapid FlexTouch je barvno kodirani napolnjen injekcijski peresnik, namenjen za uporabo z iglami za enkratno uporabo NovoFine ali NovoTwist, dolžine do 8 mm.
NovoRapid FlexTouch is a pre-filled, colour–coded, disposable pen containing insulin aspart.
NovoRapid FlexTouch je barvno-kodiran napolnjen injekcijski peresnik za enkratno uporabo, ki vsebuje insulin aspart.
NovoRapid InnoLet
Innolet
NovoRapid InnoLet 100 units/ml solution for injection Insulin aspart
NovoRapid InnoLet 100 enot/ml raztopina za injiciranje
NovoRapid InnoLet is a pre-filled disposable pen containing insulin aspart.
NovoRapid InnoLet je napolnjen injekcijski peresnik za enkratno uporabo, ki vsebuje insulin aspart.
NovoRapid InnoLet is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
NovoRapid InnoLet je napolnjen injekcijski peresnik, namenjen za uporabo z iglami za enkratno uporabo NovoFine ali NovoTwist, dolžine do 8 mm.
NovoRapid is a modern insulin (insulin analogue) with a rapid–acting effect.
Zdravilo NovoRapid je sodobni insulin (insulinski analog) s hitrim delovanjem.
NovoRapid is a rapid–acting insulin analogue.
Zdravilo NovoRapid je hitrodelujoči insulinski analog.
NovoRapid is presented as a solution for injection.
Zdravilo NovoRapid je na voljo v obliki raztopine za injiciranje.
NovoRapid may be used for CSII in pump systems suitable for insulin infusion.
Zdravilo NovoRapid se lahko uporablja za CSII v sistemih s črpalko, primernih za infundiranje insulina.
NovoRapid may be used in an infusion pump system (CSII) as described in section 4.2. Tubings in which the inner surface materials are made of polyethylene or polyolefin have been evaluated and found compatible with pump use.
Zdravilo NovoRapid se lahko uporablja v infuzijskem sistemu s črpalko (CSII), kot je opisano v poglavju 4.2. Cevke, ki imajo notranjo površino iz polietilena ali poliolefina, so ocenili in ugotovili, da se lahko uporabljajo s črpalko.
NovoRapid Penfill 100 units/ml solution for injection Insulin aspart
NovoRapid Penfill 100 enot/ml raztopina za injiciranje
NovoRapid PumpCart 100 units/ml solution for injection Insulin aspart
NovoRapid PumpCart 100 enot/ml raztopina za injiciranje
NovoRapid PumpCart contains 1.6 ml insulin aspart solution, equivalent to 160 units.
Vložek NovoRapid PumpCart vsebuje 1,6 ml raztopine insulina aspart, kar ustreza 160 enotam.
NovoRapid PumpCart is for injection under the skin (subcutaneously) via a pump.
Zdravilo NovoRapid PumpCart je namenjeno injiciranju pod kožo (subkutani uporabi) s črpalko.
NovoRapid PumpCart is presented as a solution for injection.
Zdravilo NovoRapid PumpCart je na voljo v obliki raztopine za injiciranje.
NovoRapid PumpCart is ready for use directly in the pump.
Zdravilo NovoRapid PumpCart je pripravljeno za takojšnjo uporabo v insulinski črpalki.
NovoRapid PumpCart must be protected from excessive heat and light during storage and use.
Med shranjevanjem in uporabo je treba zdravilo NovoRapid PumpCart zaščititi pred čezmerno toploto in svetlobo.
NovoRapid PumpCart should be kept out of reach of others, especially children.
Zdravilo NovoRapid PumpCart hranite nedosegljivo drugim osebam, še posebno otrokom.
NovoRapid should never be mixed with any other insulin when used in a pump.
Če zdravilo NovoRapid uporabljate v črpalki, ga nikoli ne smete mešati z nobenim drugim insulinom.
NovoRapid vial EU/1/99/119/001 EU/1/99/119/008 EU/1/99/119/015
NovoRapid viala EU/1/99/119/001 EU/1/99/119/008 EU/1/99/119/015
NovoRapid vials are for use with insulin syringes with the corresponding unit scale.
Viale zdravila NovoRapid so namenjene uporabi z insulinskimi brizgami, ki imajo ustrezno odmerno skalo.
NovoRapid will start to lower your blood sugar 10–20 minutes after you inject it, a maximum effect occurs between 1 and 3 hours after the injection and the effect lasts for 3–5 hours.
Zdravilo NovoRapid začne sladkor v krvi zniževati v 10 do 20 minutah po uporabi, doseže največji učinek v 1 do 3 urah po injiciranju in deluje od 3 do 5 ur.
NovoSeven 1 mg (50 KIU) powder and solvent for solution for injection
NovoSeven 1 mg (50 k.i.e.) prašek in topilo za raztopino za injiciranje
NovoSeven 1 mg (50 KIU) powder and solvent for solution for injection NovoSeven 2 mg (100 KIU) powder and solvent for solution for injection NovoSeven 5 mg (250 KIU) powder and solvent for solution for injection NovoSeven 8 mg (400 KIU) powder and solvent for solution for injection
NovoSeven 1 mg (50 k.i.e.) prašek in topilo za raztopino za injiciranje NovoSeven 2 mg (100 k.i.e.) prašek in topilo za raztopino za injiciranje NovoSeven 5 mg (250 k.i.e.) prašek in topilo za raztopino za injiciranje NovoSeven 8 mg (400 k.i.e.) prašek in topilo za raztopino za injiciranje
NovoSeven 2 mg (100 KIU) powder and solvent for solution for injection
NovoSeven 2 mg (100 k.i.e.) prašek in topilo za raztopino za injiciranje
NovoSeven 2 mg Powder for injection Eptacog alfa (activated) IV
NovoSeven 2 mg prašek za injekcijo aktivirani eptakog alfa i.v.
NovoSeven 5 mg (250 KIU) powder and solvent for solution for injection
NovoSeven 5 mg (250 k.i.e.) prašek in topilo za raztopino za injiciranje
NovoSeven 8 mg (400 KIU) powder and solvent for solution for injection
NovoSeven 8 mg (400 k.i.e.) prašek in topilo za raztopino za injiciranje
NovoSeven contains sucrose
Zdravilo NovoSeven vsebuje saharozo
NovoSeven contains the sugar sucrose which consists of fructose and glucose.
Zdravilo NovoSeven vsebuje sladkor saharozo, ki je sestavljen iz fruktoze in glukoze.
NovoSeven has also been studied in patients with Glanzmann’s thrombasthenia who could not be treated with platelets.
Zdravilo NovoSeven so proučevali tudi pri bolnikih z Glanzmannovo trombastenijo, ki niso mogli prejeti transfuzije trombocitov.
NovoSeven has been studied in patients with haemophilia and in patients with factor VII deficiency.
Zdravilo NovoSeven je bilo raziskano pri bolnikih s hemofilijo in pri bolnikih s pomanjkanjem faktorja VII.
NovoSeven is a blood coagulation factor.
Zdravilo NovoSeven je krvni koagulacijski faktor.
NovoSeven is a powder and solvent that are made up into a solution for injection.
Zdravilo NovoSeven je prašek in vehikel za pripravo raztopine za injiciranje.
NovoSeven is given by injection into a vein.
Zdravilo NovoSeven se daje z injekcijo v veno.
NovoSeven is now ready for injection.
Zdravilo NovoSeven je tako pripravljeno za injiciranje.
NovoSeven is now ready for injection.
Zdravilo NovoSeven je zdaj pripravljeno za injiciranje.
NovoSeven powder and solvent vials should be at room temperature at reconstitution.
Viali s praškom in topilom morata biti za pripravo ogreti na sobno temperaturo.
NovoSeven reconstituted solution is colourless and should be inspected visually for particulate matter and discolouration prior to administration.
Pripravljena raztopina zdravila NovoSeven je brezbarvna in jo je treba pred uporabo pregledati, da ne vsebuje delcev in da ni obarvana.
NovoSeven should be given as early as possible after the start of a bleeding episode.
Zdravilo NovoSeven je treba aplicirati čim prej po začetku krvavitve.
NOVOSEVEN USER INSTRUCTIONS
NAVODILA ZA UPORABO ZDRAVILA NOVOSEVEN
NovoThirteen 2500 IU powder and solvent for solution for injection
NovoThirteen 2500 i.e. prašek in vehikel za raztopino za injiciranje
NovoThirteen 2500 IU powder and solvent for solution for injection catridecacog (rDNA factor XIII)
NovoThirteen 2500 i.e. prašek in vehikel za raztopino za injiciranje katridekakog (rDNA faktor XIII)
NovoThirteen can be used in children and adolescents in the same way as in adults.
Zdravilo NovoThirteen se lahko pri mladostnikih in otrocih uporablja na enak način kot pri odraslih osebah.
NovoThirteen contains sodium
Zdravilo NovoThirteen vsebuje natrij
NovoThirteen contains the active substance catridecacog, which is identical to human coagulation factor XIII, an enzyme necessary for blood clotting.
Zdravilo NovoThirteen vsebuje zdravilno učinkovino katridekakog, ki je enaka človeškemu koagulacijskemu faktorju XIII - encimu, ki je potreben za pravilno strjevanje krvi.
NovoThirteen has no influence on the ability to drive and use machines.
Zdravilo NovoThirteen nima vpliva na sposobnost vožnje in upravljanja s stroji.
NovoThirteen is supplied as a powder and solvent for solution for injection (2500 IU powder in a vial and 3.2 ml solvent in a vial, with a vial adapter).
Zdravilo NovoThirteen je na voljo kot prašek in vehikel za raztopino za injiciranje (2500 i.e. praška v viali in 3,2 ml vehikla v viali, z nastavkom za vialo).
NovoThirteen is used for the long-term prevention of bleeding in patients with a condition called ‘congenital factor XIII A-subunit deficiency’.
Zdravilo NovoThirteen se uporablja za dolgoročno preprečevanje krvavitev pri bolnikih z motnjo, imenovano prirojeno pomanjkanje podenote A faktorja XIII.
NovoThirteen is used to prevent bleeding in patients who do not have enough factor XIII.
Zdravilo NovoThirteen uporabljamo za preprečevanje krvavitev pri bolnikih, ki jim primanjkuje faktorja XIII.
NovoThirteen user instructions
Navodila za uporabo zdravila NovoThirteen
Now 100 ml of 100 % orange juice must be drunk by the patient without delay.
Takoj po tem mora bolnik popiti 100 ml 100-% pomarančnega soka.
Now 200 ml of 100 % orange juice or 1 g citric acid in 200 ml water must be drunk by the patient without delay.
Takoj po tem mora bolnik popiti 200 ml 100-% pomarančnega soka ali 200 ml vode z 1 g citronske kisline.
Now choose the place on your body where you are going to give yourself the injection.
Zdaj izberite mesto na svojem telesu, kamor si boste injicirali zdravilo.
NOW DIALS UP TO 80 units
ZDAJ Z NASTAVITVIJO DO 80 enot
Now put the pen cap back onto the pen.
Zdaj na injekcijski peresnik ponovno namestite pokrovček injekcijskega peresnika.
Now screw the injection needle onto the pen securely by turning it in a clockwise direction (see Diagram F).
Injekcijsko iglo trdno privijte na peresnik tako, da jo obračate v smeri urnega kazalca (glejte sliko F).
Now take the syringe between index and middle finger in the upward position
Zdaj s kazalcem in sredincem primite injekcijsko brizgo in jo držite obrnjeno pokonci.
Now that the solution has been transferred into the syringe, firmly hold on to the barrel of the syringe (keeping the syringe plunger facing down) and disconnect the transparent Mix2Vial adapter from the syringe by unscrewing counterclockwise.
Ko je raztopina v injekcijski brizgi, trdno primite tulec injekcijske brizge (bat naj bo še vedno obrnjen navzdol) in snemite komplet Mix2Vial z injekcijske brizge z odvijanjem v nasprotni smeri urinega kazalca.
Now that the solution has been transferred into the syringe, firmly hold on to the barrel of the syringe (keeping the syringe plunger facing down) and disconnect the transparent Mix2Vial adapter from the syringe by unscrewing counterclockwise.
Ko je raztopina v injekcijski brizgi, trdno primite tulec injekcijske brizge (bat naj bo še vedno obrnjen navzdol) in snemite prozorni adapter seta Mix2Vial z injekcijske brizge z odvijanjem v nasprotni smeri urnega kazalca.
Now that the solution has been transferred into the syringe, firmly hold on to the barrel of the syringe (keeping the syringe plunger facing down) and disconnect the transparent Mix2Vial adapter from the syringe by unscrewing counterclockwise.
Sedaj ko je raztopina v brizgi, trdno primite brizgo (bat brizge naj gleda navzdol) in odstranite prozoren Mix2Vial adapter z brizge z odvijanjem v nasprotni smeri urnih kazalcev.
Now that the solution has been transferred into the syringe, firmly hold on to the barrel of the syringe (keeping the syringe plunger facing down) and disconnect the transparent Mix2Vial adapter from the syringe by unscrewing counterclockwise.
Zdaj ko je raztopina prenešena v injekcijsko brizgo, trdno primite tulec injekcijske brizge (bat naj bo še vedno obrnjen navzdol) in snemite komplet Mix2Vial z injekcijske brizge z odvijanjem v nasprotni smeri urinega kazalca.
Now the patient breathes gently through the straw into the breath bag.
Skozi slamico počasi izdihujte v dihalno vrečko.
Now the patient breathes gently through the straw into the breath sample container.
Bolnik naj počasi izdihuje skozi slamico v vsebnik za vzorec izdihnjenega zraka.
Now the patient breathes gently through the straw into the breath sample container.
Skozi slamico počasi izdihujte v vsebnik za vzorec dihanja.
Now the patient breathes gently through the straw into the sample tube until the inside of the sample tube steams up.
Skozi slamico počasi izdihujte v epruveto, dokler se notranja površina epruvete ne zarosi.
Now the patient breathes gently through the straw until the inner surface of the sample tube steams up.
Bolnik naj počasi izdihuje skozi slamico, dokler se notranja površina epruvete ne zarosi.